Regenerex Pharma (RGPX) Return on Equity (2011 - 2025)

Regenerex Pharma (RGPX) has 13 years of Return on Equity data on file, last reported at 0.01% in Q3 2025.

• Quarterly Return on Equity changed 0.0% year-over-year to 0.01% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, down 1.0% from the prior year.
• Return on Equity climbed to 0.01% in Q3 2025 per RGPX's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Equity topped out at 0.01% in Q3 2023 and bottomed at 0.0% in Q2 2021.
• The 5-year median for Return on Equity is 0.0% (2024), against an average of 0.0%.
• The widest annual swing landed in 2023, when Return on Equity grew 1 bps; it then fell 1 bps in 2024.
• Tracing RGPX's Return on Equity over 5 years: stood at 0.0% in 2021, then advanced by 3 bps to 0.0% in 2022, then soared by 471 bps to 0.01% in 2023, then tumbled by 66 bps to 0.0% in 2024, then jumped by 119 bps to 0.01% in 2025.
• Per Business Quant, the three latest RGPX Return on Equity figures stand at 0.01% (Q3 2025), 0.01% (Q2 2025), and 0.01% (Q1 2025).

Peer Comparison